Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer

Clinical trial NCT03207139 · COMPLETED

Trial details

NCT number: NCT03207139
Sponsor: Chang Gung Memorial Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Latent Cancer Prostate

Start date: 2017-06-22
Primary completion: 2019-06-30
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.